Cash

Latest balance sheet

Net assets

£7M

+4.9% vs 2022

Employees

4

0% vs 2022

Profit before tax

Period ending 2023-12-31

Profile

Company number
NI040832
Status
Active
Incorporation
2001-05-15
Last accounts made up
2024-12-31
Account category
FULL
Primary SIC
86101
Hubs
UK Healthcare

Net assets

9-year trend · vs UK Healthcare median

£0£5m£10m201920192020202020212021202220222023
ERGEA BELFAST LIMITED

Accounts

9-year trend · latest 2023-12-31

Metric Trend 2019-01-012019-12-312020-01-012020-12-312021-01-012021-12-312022-01-012022-12-312023-12-31
Turnover
Operating profit
Profit before tax
Net profit
Cash
Total assets less current liabilities £4,979,858
Net assets £4,915,293£5,734,571£6,336,349£7,043,038£7,389,141
Equity £4,915,293£5,734,571£6,336,349£7,043,038£7,389,141
Average employees 33444
Wages

Values shown as filed in iXBRL accounts. indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Audit & accounting basis

From AI-extracted PDF accounts

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Sopher + Co LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have conducted a business review and have a reasonable expectation that the Company have adequate resources to continue in operational existence until 31 December 2026, which is more than 12 months from the date of approval of these financial statements. Even in a zero-growth scenario where no new business is added, the Company generates positive cashflows. A material proportion of the business comes from the NHS (backed by UK Government), and from long-term contracts providing certainty of income beyond the Going Concern assessment period. The Directors have assessed the political, economic, social and technology risks and believe the Company is well placed to successfully manage these risks. On the basis of their assessment of the above, they continue to adopt the going concern basis of accounting in preparing the annual financial statements for the 12 months from the date of approval of the financial statements (the going concern period).”

Subsidiaries

Significant events

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers

People

5 active · 8 resigned

Name Role Appointed Born Nationality
CORTI, Michele Director 2020-11-27 Dec 1978 Italian
GRAVES, Mark Timothy Director 2026-02-19 Apr 1974 English
MUOLO, John Edward Director 2012-11-29 Jan 1955 British,American
ROLFE, David Anthony Director 2025-10-15 Jul 1972 British
WHEELER, Victor James Director 2025-10-15 Jan 1972 British
Show 8 resigned officers
Name Role Appointed Resigned
GILDEN, Ronald Secretary 2001-05-15 2012-11-29
DAVIES, William Richard Director 2003-02-26 2012-11-29
ERCIL, Aylin Director 2003-02-26 2003-09-01
GILDEN, Ronald Wayne Director 2001-05-15 2012-11-29
REZENDE, Robin Director 2013-01-24 2025-10-15
REZENDE, Robin Director 2003-09-01 2012-11-27
ROLFE, David Anthony Director 2012-11-29 2016-09-24
TOWNSLEY, Michael Colin Director 2001-05-15 2004-05-05

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Ergea Healthcare Leeds And Belfast Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-10-24 Active
Medipass Healthcare Limited Corporate entity Shares 75–100% 2016-07-01 Ceased 2016-10-24
Medipass Healthcare Limited Corporate entity Shares 75–100% 2016-04-06 Ceased 2025-07-10

Filing timeline

Last 20 of 102 total filings

Date Type Category Description
2026-03-18 CH01 officers change person director company with change date
2026-02-20 AP01 officers appoint person director company with name date
2025-12-02 AD01 address change registered office address company with date old address new address
2025-11-28 PSC05 persons-with-significant-control change to a person with significant control
2025-11-26 PSC05 persons-with-significant-control change to a person with significant control
2025-10-16 AP01 officers appoint person director company with name date
2025-10-16 AP01 officers appoint person director company with name date
2025-10-16 TM01 officers termination director company with name termination date
2025-09-09 AA accounts accounts with accounts type full
2025-07-25 PSC07 persons-with-significant-control cessation of a person with significant control
2025-05-30 CS01 confirmation-statement confirmation statement with no updates
2024-07-23 AA accounts accounts with accounts type small
2024-07-01 CS01 confirmation-statement confirmation statement with no updates
2023-08-30 AD01 address change registered office address company with date old address new address
2023-06-15 CS01 confirmation-statement confirmation statement with no updates
2023-05-22 AA accounts accounts with accounts type small
2023-05-05 PSC02 persons-with-significant-control notification of a person with significant control
2023-05-05 PSC07 persons-with-significant-control cessation of a person with significant control
2023-03-01 CERTNM change-of-name certificate change of name company
2022-07-27 AA accounts accounts with accounts type small

Credit score

Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage

Credit score requires total assets, EBIT (operating profit / PBT) — not present in the latest extracted accounts.

Activity Score

Filings velocity, capital events, officer churn, accounts trajectory

Activity Score not yet computed for this company.

Official Companies House page